Article Details
Retrieved on: 2022-11-15 05:11:52
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
TOKYO (Reuters) - Japan's Daiichi Sankyo Co said on Tuesday its mRNA-based COVID-19 vaccine had reached its primary endpoint in a trial of the ...
Article found on: wtvbam.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here